| Literature DB >> 28408316 |
Zhiqiang Wang1, Peng Sun2, Chun Gao2, Ji Chen2, Jun Li2, Zhonghao Chen2, Ming Xu2, Jun Shao2, Yunpeng Zhang2, Jiang Xie3.
Abstract
Aberrant activation of beta-catenin/TCF signaling is one of the hallmarks of colon cancer. It is of great interest to study the mechanism for the regulation of beta-catenin/TCF signaling. In this study, it was found that LRP1B was down-regulated in colon cancer tissues and inhibited the growth, migration and metastasis of colon cancer cells. The molecular mechanism study revealed that LRP1B interacted with DVL2, inhibited the interaction between DVL2 and Axin, and negatively regulated beta-catenin/TCF signaling. Taken together, our study demonstrated the suppressive roles of LRP1B in the progression of colon cancer, implicating that restoring the function of LRP1B would be a promising strategy for the treatment of colon cancer.Entities:
Keywords: Beta-catenin/TCF signaling; Cell growth and migration; Colon cancer; LRP1B
Mesh:
Substances:
Year: 2017 PMID: 28408316 DOI: 10.1016/j.yexcr.2017.04.010
Source DB: PubMed Journal: Exp Cell Res ISSN: 0014-4827 Impact factor: 3.905